IRIS Accounts Production v24.1.0.578 04938737 Board of Directors 1.1.23 31.12.23 31.12.23 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh049387372022-12-31049387372023-12-31049387372023-01-012023-12-31049387372021-12-31049387372022-01-012022-12-31049387372022-12-3104938737ns15:EnglandWales2023-01-012023-12-3104938737ns14:PoundSterling2023-01-012023-12-3104938737ns10:Director12023-01-012023-12-3104938737ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3104938737ns10:SmallEntities2023-01-012023-12-3104938737ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3104938737ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3104938737ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3104938737ns10:FullAccounts2023-01-012023-12-310493873712023-01-012023-12-3104938737ns10:OrdinaryShareClass12023-01-012023-12-3104938737ns10:Director22023-01-012023-12-3104938737ns10:CompanySecretary12023-01-012023-12-3104938737ns10:RegisteredOffice2023-01-012023-12-3104938737ns5:CurrentFinancialInstruments2023-12-3104938737ns5:CurrentFinancialInstruments2022-12-3104938737ns5:ShareCapital2023-12-3104938737ns5:ShareCapital2022-12-3104938737ns5:RetainedEarningsAccumulatedLosses2023-12-3104938737ns5:RetainedEarningsAccumulatedLosses2022-12-3104938737ns5:NetGoodwill2023-01-012023-12-3104938737ns5:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3104938737ns5:OwnedOrFreeholdAssetsns5:LandBuildings2023-01-012023-12-3104938737ns5:FurnitureFittings2023-01-012023-12-3104938737ns5:MotorVehicles2023-01-012023-12-3104938737ns5:ComputerEquipment2023-01-012023-12-3104938737ns5:NetGoodwill2022-12-3104938737ns5:NetGoodwill2023-12-3104938737ns5:NetGoodwill2022-12-3104938737ns5:LandBuildings2022-12-3104938737ns5:FurnitureFittings2022-12-3104938737ns5:MotorVehicles2022-12-3104938737ns5:ComputerEquipment2022-12-3104938737ns5:LandBuildings2023-01-012023-12-3104938737ns5:LandBuildings2023-12-3104938737ns5:FurnitureFittings2023-12-3104938737ns5:MotorVehicles2023-12-3104938737ns5:ComputerEquipment2023-12-3104938737ns5:LandBuildings2022-12-3104938737ns5:FurnitureFittings2022-12-3104938737ns5:MotorVehicles2022-12-3104938737ns5:ComputerEquipment2022-12-3104938737ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3104938737ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3104938737ns10:OrdinaryShareClass12023-12-3104938737ns10:Director222022-12-3104938737ns10:Director222021-12-3104938737ns10:Director222023-01-012023-12-3104938737ns10:Director222022-01-012022-12-3104938737ns10:Director222023-12-3104938737ns10:Director222022-12-31
REGISTERED NUMBER: 04938737 (England and Wales)













Unaudited Financial Statements

for the Year Ended 31 December 2023

for

Haswell Pharmacy Limited

Haswell Pharmacy Limited (Registered number: 04938737)






Contents of the Financial Statements
for the Year Ended 31 December 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Haswell Pharmacy Limited

Company Information
for the Year Ended 31 December 2023







DIRECTORS: S Elliott
A J Webber





SECRETARY: A J Webber





REGISTERED OFFICE: 80 Front Street
Haswell
Co. Durham
DH6 2BL





REGISTERED NUMBER: 04938737 (England and Wales)





ACCOUNTANTS: Anderson Barrowcliff LLP
Chartered Accountants
3 Kingfisher Court
Bowesfield Park
Stockton on Tees
TS18 3EX

Haswell Pharmacy Limited (Registered number: 04938737)

Balance Sheet
31 December 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 1 8,650
Tangible assets 5 184,462 187,146
184,463 195,796

CURRENT ASSETS
Stocks 6 24,021 19,329
Debtors 7 50,583 54,643
Cash at bank and in hand 78,526 65,814
153,130 139,786
CREDITORS
Amounts falling due within one year 8 59,532 60,921
NET CURRENT ASSETS 93,598 78,865
TOTAL ASSETS LESS CURRENT
LIABILITIES

278,061

274,661

PROVISIONS FOR LIABILITIES 1,000 400
NET ASSETS 277,061 274,261

CAPITAL AND RESERVES
Called up share capital 9 100 100
Retained earnings 276,961 274,161
SHAREHOLDERS' FUNDS 277,061 274,261

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Haswell Pharmacy Limited (Registered number: 04938737)

Balance Sheet - continued
31 December 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 12 April 2024 and were signed on its behalf by:





A J Webber - Director


Haswell Pharmacy Limited (Registered number: 04938737)

Notes to the Financial Statements
for the Year Ended 31 December 2023

1. STATUTORY INFORMATION

Haswell Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest £.

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2004, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - 2% on cost
Fixtures and fittings - 15% - 33.3% on cost
Motor vehicles - 25% on reducing balance
Computer equipment - 25% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the current or past reporting periods. It is measured at the amount expected to be paid or recovered using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax represents the future tax consequences of transactions and events recognised in the financial statements of current and previous periods. It is recognised in respect of all timing differences, with certain exceptions. Timing differences are differences between taxable profits and total comprehensive income as stated in the financial statements that arise from the inclusion of income and expense in tax assessments in periods different from those in which they are recognised in the financial statements. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date that are expected to apply to the reversal of timing differences.

Haswell Pharmacy Limited (Registered number: 04938737)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2022 - 5 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 January 2023
and 31 December 2023 173,000
AMORTISATION
At 1 January 2023 164,350
Amortisation for year 8,649
At 31 December 2023 172,999
NET BOOK VALUE
At 31 December 2023 1
At 31 December 2022 8,650

5. TANGIBLE FIXED ASSETS
Fixtures
Freehold and Motor Computer
property fittings vehicles equipment Totals
£    £    £    £    £   
COST
At 1 January 2023 223,247 43,916 2,500 4,114 273,777
Additions - 3,400 - - 3,400
At 31 December 2023 223,247 47,316 2,500 4,114 277,177
DEPRECIATION
At 1 January 2023 39,237 43,831 1,932 1,631 86,631
Charge for year 4,374 539 142 1,029 6,084
At 31 December 2023 43,611 44,370 2,074 2,660 92,715
NET BOOK VALUE
At 31 December 2023 179,636 2,946 426 1,454 184,462
At 31 December 2022 184,010 85 568 2,483 187,146

6. STOCKS
2023 2022
£    £   
Stocks 24,021 19,329

Haswell Pharmacy Limited (Registered number: 04938737)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 34,173 41,464
Other debtors 9,190 10,497
Directors' current accounts 4,756 -
Taxation - 2,029
Prepayments and accrued income 2,464 653
50,583 54,643

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 43,503 46,448
Taxation 1,770 -
Social security and other taxes 1,520 2,410
Other creditors 8,944 8,618
Accruals and deferred income 3,795 3,445
59,532 60,921

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
100 Ordinary £1 100 100

10. OTHER FINANCIAL COMMITMENTS

Total financial commitments which are not included in the balance sheet amount to £2,216 (2022 - £3,482) relating to amounts payable under operating leases.

11. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 December 2023 and 31 December 2022:

2023 2022
£    £   
S Elliott
Balance outstanding at start of year - -
Amounts advanced 4,756 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 4,756 -